Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$10.34 - $12.81 $20 Million - $24.8 Million
-1,935,200 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$8.12 - $13.12 $15.7 Million - $25.4 Million
1,935,200 New
1,935,200 $23.9 Million
Q2 2019

Aug 14, 2019

SELL
$8.12 - $15.72 $33.1 Million - $64.1 Million
-4,079,000 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$15.58 - $20.01 $63.6 Million - $81.6 Million
4,079,000 New
4,079,000 $64 Million
Q4 2017

Feb 14, 2018

SELL
$11.23 - $19.1 $4.55 Million - $7.75 Million
-405,500 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$15.41 - $32.17 $6.25 Million - $13 Million
405,500
405,500 $7.14 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $23.7B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.